March 24, 2020
Digital pediatric-behavioral-health company Cognoa announced today the appointment of David Happel as its new CEO. He comes from biopharmaceutical company Chrono Therapeutics, which he led as president, CEO and director, as well as stints at Horizon Therapeutics, Raptom Pharma, Allergen Research Corporation and others.
Brent Vaughan, Cognoa's cofounder and former CEO, will be serving in an...
March 9, 2020
Digital therapeutics company Dario Health Corp named Yadin Shemmer and Adam Stern to the board of directors.
This isn’t Shemmer’s first go-round in digital health. He served as the CEO of medication management platform Mango Health for two years. He also worked at Everyday Health and cofounded Better2Know.
Stern comes from the world of finance. He is currently the CEO of SternAegis Ventures and...
February 12, 2020
Cognoa has entered a new partnership with Autism Learning Partners (ALP) that will provide parents with the Cognoa for Child Development app. The tool helps parents log their child’s developmental progress and offers personalized activity suggestions to help support their growth. ALP providers, meanwhile, can review the logs for evidence of autism spectrum disorder to better inform their care and...
December 4, 2019
Dr. John Halamka, a longtime CIO, executive director and professor tied to Harvard-affiliated Beth Israel Deaconness Medical Center, will be joining the Mayo Clinic on January 1 as the new president of its Mayo Clinic Platform — a digital health project that will deploy “artificial intelligence, the internet of things and an ecosystem of partners,” he wrote in a blog post announcing the move....
October 28, 2019
The past few days have seen new pivotal trial announcements from two startups eyeing FDA submissions for their digital health offerings.
On Thursday Cognoa unveiled an investigation for its pediatric development monitoring and diagnostic tool. This will be a multi-site, prospective, blinded, active comparator study of the tool, which is intended to support primary care autism diagnoses among...
April 10, 2019
Cognoa, the maker of a machine learning-based app for tracking children’s health and development, announced today that it has exclusively licensed an AI system designed to improve socialization skills in children with autism spectrum disorder (ASD) from the Stanford University School of Medicine.
Called Superpower Glass, the technology runs on Google Glass and is designed to encourage children’s...
November 21, 2018
Papa, a startup that schedules companion visits for lonely seniors, has partnered with Humana to support those covered under Medicare Advantage. The Florida-based company trains and provides college-aged assistants to meet and spend time with seniors in their home, and bills itself as a “grandkids on demand” service.
“At Humana, we know if we truly want to impact the health of our Medicare...
August 27, 2018
In May, a pair of studies were published in the journals Autism Research and the Journal of the American Medical Informatics Association (JAMIA) that evaluated Cognoa’s artificial intelligence-based tool for early identification of autism in children. While both investigations suggest that the tool’s performance significantly exceeded those of other standardized screeners, comparing the two...
February 21, 2018
Palo Alto, California-based Cognoa’s machine learning app for pediatric behavioral health has received categorization from the FDA as a diagnostic medical device for autism, according to an announcement from the company.
By analyzing parent-provided information and videos of a child’s natural behavior, the company’s app uses machine learning to provide an assessment of whether that child is...
March 27, 2017
Palo Alto, California-based Cognoa, which makes an app to assess child development, has raised $11.6 million in a round led by existing investor Morningside. This brings the company’s total funding to over $20 million.
By analyzing parent-provided information and videos of a child’s natural behavior, the Cognoa app uses machine learning to provide an assessment of whether that child is developing...